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Abstract 
 
Background: Schizophrenia is a heterogeneous disorder that is characterized by varying levels of hallucinations, delusions, 
negative symptoms, and disorganized features. The presence and severity of neurodevelopmental precursors and premorbid 
psychopathology also vary among individuals. To fully understand individual patients and to sort out phenotypic heterogeneity 
for genetic research studies, instruments designed to collect developmental history relevant to schizophrenia may be helpful. 
Objective: The goal was to describe a pair of self-report and parent-report instruments developed for the purpose of 
collecting the developmental history of patients with known or suspected schizophrenia spectrum disorders. 
Method: Two developmental history instruments were designed for use in studies of brain morphology and cognition in 
schizophrenia probands and their unaffected siblings. The instruments focus mainly on motor abnormalities and other features 
that have been described as schizophrenia precursors.  
Results: The Motor Skills History Form is a brief self-report form that asks about patients’ childhood and adolescent motor 
abilities as well as their current motor functioning. The Developmental & Motor History Form is a more detailed parent-rated 
form that covers aspects of patients’ early (infant/preschool) development; their childhood and adolescent motor abilities; 
any childhood behaviors that may be related to later psychosis risk; and their history of any neurological, emotional, or 
cognitive disorders diagnosed during childhood or adolescence. The instruments can be used either for interviews or as self-
administered questionnaires. The parent-rated form has been used for research and for the clinical assessment of children and 
adolescents with complex neurodevelopmental presentations with or without strong evidence of schizophrenia risk.  
Conclusions: The collection of developmental history information is important when evaluating individuals with 
schizophrenia and related disorders. The Motor Skills History Form and the Developmental & Motor History Form can be 
used to collect this information for clinical evaluation or research purposes. 
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Introduction 
The collection of a developmental history during the 
clinical evaluation of patients with schizophrenia and 
related disorders is important for the following 
reasons: 
1. When evaluating schizophrenia risk states, a 
history of developmental delays (1-5), abnormal 
movements (6-9), motor coordination problems 
(10,11), cognitive dysfunction(2,12,13), and specific 
psychiatric symptoms or behaviors (14-17) may help 
to predict the risk of conversion to schizophrenia or 
another psychotic disorder. 
2. A history of premorbid neurodevelopmental 
disorders such as autism spectrum disorder (ASD), 
attention-deficit/hyperactivity disorder (ADHD), or 
learning disorders may require specific interventions 
or predict an individual’s potential level of 
functioning and the degree of support that he or she 
will continue to need even after any active psychotic 
symptoms are under good control. 
3. Individuals with a history of social and non-
social cognitive problems may benefit from cognitive 
remediation (18-22). 
4. The presence of complex neurodevelopmental 
problems may suggest a higher likelihood that an 
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abnormality would be found with genetic testing 
such as chromosomal microarray or whole exome 
sequencing (23-33). If a specific genetic cause is 
found (e.g., 22q11.2 deletion, which is present in 4% 
of patients with childhood-onset schizophrenia and 
0.3% to 1% of patients with adult-onset 
schizophrenia [23]), this may warrant specific 
medical monitoring or treatment. 
This article describes a set of self-report and 
parent-report instruments that were originally 
designed in 2005 for the collection of developmental 
history information from research assessment 
participants at the Conte Center for the 
Neuroscience of Mental Disorders at Washington 
University School of Medicine. At the Conte Center, 
the instruments were used in a study of brain 
morphology and cognition in research subjects with 
schizophrenia and their unaffected siblings (34-39). 
Motor abnormalities such as abnormal involuntary 
movements and poor motor coordination that were 
present before a schizophrenia diagnosis were of 
particular interest based on a review of existing 
literature about neurodevelopment in patients with 
schizophrenia.  
We will now focus on the description of the 
instruments themselves, and future publications will 
provide reports of actual research findings as they 
become available. 
 
Methods 
General Description of the Instruments 
Self-report and parent-report questionnaires were 
developed on the basis of the existing literature (as 
referenced previously) and personal experience 
working with child, adolescent, and adult patients 
with schizophrenia or schizophrenia risk states 
(Table 1). The Motor Skills History Form (MSHF) is 
a brief self-report instrument that focuses on 
elements of the developmental history (particularly 
motor function) that individuals may remember 
about themselves, even after they have reached 
adulthood. The Developmental & Motor History 
Form (DMHF) is a parent-report measure that 
covers some of the same areas (particularly related to 
child and adolescent motor abilities) and that also 
asks about additional childhood and adolescent 
symptoms, behaviors, and diagnoses. It also covers 
relevant aspects of early (infant and preschool) 
development.  
There are problems inherent to the collection of 
retrospective developmental history, particularly 
related to an individual’s poor recall of events that 
occurred years ago. Child, adolescent, and adult 
patients are unlikely to know the details of their own 
early childhood development unless a parent has 
provided this information to them. However, they 
may remember aspects of their motor development 
history, particularly if they experienced poor motor 
coordination that affected their ability to participate 
in sports and other activities during childhood or 
adolescence. They may remember how their abilities 
compared with those of other children their age, 
whether they were teased about their poor abilities, 
whether they avoided physical education classes due 
to their lack of ability, their degree of participation in 
organized sports, and perhaps the age at which they 
learned to ride a bicycle. Individuals can also 
comment on their perception of their own current 
motor abilities and any difficulties that they may have 
had learning complex motor behaviors, such as 
driving a car. Therefore, the self-report MSHF 
focuses on these elements. The MSHF focuses on 
childhood and adolescence, because it is unlikely that 
individuals will have an accurate recollection of their 
infancy and preschool years. 
Sections A and B of the MSHF focus exclusively 
on the age range of 5 to 18 years. Section A asks 
about specific childhood and adolescent motor 
abilities, while section B focuses on experiences that 
may have occurred as a consequence of the level of 
motor ability. Parent-report versions of some of the 
MSHF Section A and B items are also included in 
Section C of the DMHF.  
Because they ask about current abilities and events, 
Sections C and D of the MSHF include coverage of 
adult experiences if the individual completing the 
questionnaire is an adult.  Section C of the MSHF 
asks about current motor functioning, including the 
degree of difficulty experienced when learning to 
drive a car (if applicable), an overall rating of current 
athletic ability, and current interest in team sports 
game participation for recreational purposes. Section 
D of the MSHF asks about any neurological or other 
medical disorders that may have affected motor skills 
or athletic ability, the patient’s age and sex, and the 
date of the rating. 
The DMHF collects parent-report information 
about patients’ developmental and motor history. 
Section A addresses infancy and the preschool years, 
and this is followed by sections B through D, which 
focus on childhood and adolescence. Parents often 
have difficulty remembering the details of their 
children’s early developmental history, particularly 
the exact ages at which their children reached specific 
developmental milestones. Collecting information 
about the timing of early developmental milestones 
(i.e., the ages at which patient first sat, crawled, 
walked, spoke words, used phrases, and conversed in 
full sentences) may still be useful in terms of getting 
a general idea of whether development was seriously 
delayed, so the DMHF does include questions about 
these. In the case of motor milestones, there is also 
an item that asks about the parent’s level of certainty 
regarding the timing. Even if parents do not 
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remember the exact timing of developmental 
milestones, they are likely to remember major events 
such as concerns about development that led to an 
evaluation of motor or speech delays or to the 
provision of speech, occupational, or physical 
therapy to address developmental problems. Thus, 
questions about the evaluation and treatment of 
developmental concerns are also included. 
 
 
 
 
 
TABLE 1. Descriptions and Sections of the Motor Skills History Form and the Developmental & Motor History Form 
Motor Skills History Form (MSHF) Developmental & Motor History Form (DMHF) 
Self-report Parent-report 
Focuses on the developmental history, particularly motor function during the age 
range of 5 to 18 years. Also asks about current motor abilities. 
Focuses on the developmental history from infancy through age 18 years, and 
also asks about additional symptoms, behaviors, and diagnoses during the same 
time period 
Section A: Motor Abilities Section A: Early Development 
Section B: Motor Consequences Section B: Childhood & Adolescent Behavior 
Section C: Current Motor Functioning Section C: Child & Adolescent Motor Skills 
Section D: Untitled section including questions about past and current medical 
disorders that may have affected motor skills. 
Section D: Child & Adolescent Neurological, Emotional, and Cognitive Disorders 
Note. Section C of the DMHF includes some items that are also asked in sections A and B of the MSHF. Both instruments also collect information about age, sex, and 
date of rating at the end of section D. 
 
 
 
 
Studies of infants and children with a high genetic 
risk for schizophrenia due to parental psychiatric 
history indicate that these children often show 
atypical patterns of development and certain types of 
abnormal movements, even without the presence of 
clearly abnormal delays in motor milestones (5,6). 
For this reason, the early childhood section of the 
DMHF includes an item that asks whether the child 
walked before learning to crawl. There is also a series 
of items that ask about any specific motor behaviors, 
such as atypical activity level, abnormal muscle tone, 
unusual ways of walking or running, and various 
abnormal movements that may have been observed 
during infancy and the preschool years. To help 
screen for possible ASD, there are some questions 
about sensory sensitivities, the child’s response to 
being held, and any speech or language delays. There 
are also questions about any medications taken 
during early childhood and whether these seemed to 
affect motor skills or behavior.  
Section B of the DMHF contains questions about 
general childhood behaviors that may indicate some 
level of increased risk for schizophrenia. Some of 
these behaviors have been described as 
characteristics of children with childhood 
schizophrenia, or they may have been reported as 
precursor behaviors that appeared in at-risk children 
who later developed schizophrenia. For example, 
observations of general unusual behaviors and 
atypical peer behaviors (e.g., a preference for playing 
alone, difficulty playing with more than one child at 
a time) have been made regarding children who have 
been diagnosed with childhood schizophrenia (40). 
In addition, teacher-reports of unusual emotional 
reactions, inappropriate behaviors, and uneasiness 
about criticism during childhood are some of the 
unusual behaviors that have predicted the develop-
ment of adulthood schizophrenia spectrum disorders 
among high-risk individuals (15,17). Other items 
within Section B of the DMHF ask about relatively 
common and non-specific childhood symptoms that 
may possibly be relevant on the basis of general 
clinical experience. 
Section C of the DMHF focuses on childhood and 
adolescent motor abilities, beginning with the motor 
ability items from section A of the MSHF. Since the 
self-report MSHF has this same set of items, it is 
possible to compare parent-reports with self-reports. 
There are also some questions about motor function 
and sports participation that are similar to items 
found in Section B of the MSHF.  
Section D of the DMHF asks about specific 
diagnoses that the child was given during childhood 
or adolescence, any medications that may have 
affected child or adolescent motor function or 
behavior, the child’s age and sex, and the date of the 
rating. 
 
Use and Scoring 
For clinical use, scoring of the MSHF and DMHF is 
not essential, but information gathered from the 
forms can enhance the level of developmental and 
psychiatric history that is obtained during 
assessment. Without any need to calculate scores, the 
information obtained can be used to assist decision 
making with regard to further diagnostic testing (e.g., 
to assess the need for detailed autism assessment or 
genetic testing). The methods of scoring discussed in 
the following paragraphs may be most important for 
researchers who seek to compare the levels of 
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developmental abnormalities among their research 
participant groups. 
Section A of the MSHF is composed of 14 items 
that ask the individual to rate their own motor skill 
abilities as compared with peers of the same age on a 
scale of 1 to 5, with 1 = far below average, 2 = 
somewhat below average, 3 = average, 4 = somewhat 
above average, and 5 = excellent. Participants are 
asked to rate themselves twice: once for childhood (5 
to 12 years old) and once for adolescence (13 to 18 
years old). If the scale is used for patients who are 
less than 13 years old, the ratings that apply to 
adolescent abilities can be skipped. The scores on 
these items can be averaged to determine a Total 
Motor Abilities Score, which provides direct 
information about an individual’s perception of his 
or her ability level. For example, a total score of 2.5 
would indicate that, on average, the individual 
perceives that his or her various motor abilities were 
somewhere between the average and somewhat 
below average range during the specified period. 
Suggested subscales for this section include Gross 
Motor Abilities (items 1 through 8), Balance (items 9 
through 11), and Fine Motor Abilities (items 12 
through 14). These can be calculated by averaging the 
scores of the relevant items. Separate scores for 
childhood and adolescence can be calculated, or 
overall child and adolescent scores can be calculated 
by averaging the childhood and adolescence items 
together. It may also be useful to develop alternate 
subscales on the basis of factor analysis after an 
adequate amount of research data has been collected. 
Section C of the DMHF includes 14 questions 
about motor abilities that are identical to those of 
Section A of the MSHF. This allows for easy 
comparison between parent-report and self-report 
perceptions.  
Section B of the MSHF focuses on behaviors or 
experiences that may have occurred as a result of 
poor motor coordination, such as a dislike of physical 
education classes, teasing about poor physical 
abilities, being clumsy or accident-prone, learning to 
ride a bicycle at a later age (item C15 of the DMHF 
asks the same bicycle information), and the order in 
which the participant was asked to participate in 
sports teams. Items B1 through B5 can be averaged 
to get a score, or they may be examined individually. 
This section also contains items that ask about 
participation in organized sports (MSHF items B6 
through B8) and any history of receiving physical or 
occupational therapy (B9 and B9a). The number of 
sports listed may be useful as a variable for analysis. 
DMHF items C16 through C20a also cover sports 
participation and therapy history. 
The items in sections C and D of the MSHF (see 
earlier description) may be best considered as 
individual items rather than being combined into any 
subscales. 
Section A of the DMHF requires parents to recall 
information about their children’s infant and 
preschool years. As in some other sections of these 
instruments, respondents are asked to give their best 
guesses if they are unsure about the answers. This 
instruction may minimize the tendency for some 
respondents to skip items due to minor uncertainties 
and thus allow a greater amount of data to be 
collected. However, when interpreting this particular 
section, evaluators should keep in mind that there 
may be a higher potential for inaccurate responses 
when parents are trying to recall their children’s 
earliest years. Because it is expected that many 
parents will not accurately recall the exact dates of 
developmental milestones, caution is warranted 
when using and interpreting any scores that are based 
on the ages at which milestones were met. The 
comparison of these values among subject groups 
may still be useful, especially for cases in which baby 
books or medical records have been used to confirm 
the exact timing of developmental milestones. The 
endorsement of dichotomous yes/no answers 
regarding specific behaviors and problems, early life 
evaluation for developmental concerns, or specific 
treatment interventions can be compared among 
research subject groups as appropriate. The 
questions that ask about the presence or absence of 
specific early childhood motor behaviors (items A4 
through A24) can be used to create a score by 
counting the number of positive responses. Because 
such behaviors may or may not be noticed even if 
they are present, a “yes” response can be considered 
to indicate that the behavior was frequent or obvious 
enough for the parent to recall seeing it, and a “no” 
or blank response may indicate that the behavior was 
either not present or not obvious or frequent enough 
for the parent to clearly remember it. As long as most 
items in the section are answered, it may be 
appropriate to recode any missing responses as “no” 
responses. 
Items on Section B of the DMHF, which address 
childhood and adolescent behavior, can either be 
considered separately or coded such that each “yes” 
answer contributes a point to a total symptom count 
score. Section D items about childhood and 
adolescent disorders can be scored in a similar 
manner, and subscales can be created to separately 
indicate the number of neurodevelopmental 
disorders (items D1 through D4 and D6 through 
D13) and other psychiatric disorders (items D14 
through D16) that were diagnosed. 
The MSHF and the DMHF were first used in the 
previously mentioned Conte Center research study, 
which focused on individuals with schizophrenia and 
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their unaffected siblings. Subjects in that study were 
mainly adolescents and young adults who were in the 
range of 14 to 30 years old. The measures were later 
used in a separate study of child, adolescent, and 
adult sibling pairs that were discordant for ADHD. 
Research use of the instruments for both projects 
was approved by the Washington University Human 
Research Protection Office. 
 
Results 
The original full versions of the MSHF and DMHF 
are provided along with this report; see the associated 
Supplemental Materials. The analysis of collected 
MSHF and DMHF research data is ongoing and will 
be reported in the future. In addition to being used 
in the previously discussed research studies, the 
DMHF has been used in non-research clinical 
diagnostic evaluations of children and adolescents 
with complex neurodevelopmental problems or with 
features that suggest high risk for the development 
of a schizophrenia spectrum disorder. These 
instruments have mainly been used as self-
administered questionnaires, but they can also be 
used as interview-based measures. Any questions 
regarding instructions for the use of these 
instruments, future updated versions, or progress 
toward normative data collection can be directed to 
the author. 
 
Discussion 
Assessment of the developmental history is 
appropriate as part of clinical or research evaluations 
of children, adolescents, and adults with 
schizophrenia or with risk factors for the 
development of a schizophrenia spectrum disorder. 
A developmental history is often a key component of 
the standard clinical evaluations performed by child 
and adolescent psychiatrists, whether or not 
schizophrenia is part of the differential diagnosis. 
However, because schizophrenia is often diagnosed 
during late adolescence or early adulthood, 
individuals with schizophrenia may first be evaluated 
and treated by general psychiatrists, who may or may 
not routinely ask many questions about 
developmental history as part of their assessments. 
Even if an evaluating psychiatrist or psychologist 
does ask about the patient’s developmental history, 
the questions asked may not be tailored toward the 
collection of information that is particularly relevant 
to the developmental course of schizophrenia.  
The MSHF and the DMHF are presented here as 
one method for the collection of developmental 
history information, with an emphasis on aspects that 
are relevant to the natural developmental course of 
schizophrenia spectrum disorders. These 
questionnaires are particularly appropriate for use in 
individuals with known or suspected schizophrenia 
spectrum disorders, but they can also be useful for 
the evaluation of children, adolescents, and adults 
with complex forms of psychopathology that do not 
necessarily indicate schizophrenia risk, such as the 
co-occurrence of multiple neurodevelopmental 
problems or behavioral disturbances in young 
patients who do not have any known family genetic 
or other risk factors for psychosis. 
In clinical practice, when evaluating children with 
symptoms that are suggestive of psychosis, the 
developmental history may contribute to the making 
of decisions about whether to order genetic testing. 
One study found disease-related copy-number 
variants (CNVs) in 11.9% of patients with 
childhood-onset schizophrenia, and a few of these 
individuals (4 out of the 15 with CNV findings) 
actually had a second neuropsychiatric-disorder–
associated CNV (23). These CNV rates were 
significantly higher than those of the two adult 
schizophrenia samples that were used for 
comparison, which were 1.4% and 4.9%. One well-
established genetic cause of schizophrenia is 22q11.2 
deletion syndrome, which is estimated to be present 
in 0.3% to 1% of patients with adult-onset 
schizophrenia and in 4% of patients with childhood-
onset schizophrenia (23). Individuals with 22q11.2 
deletion have about a 30% chance of developing 
schizophrenia or another psychotic disorder during 
their lifetimes (41). These individuals also frequently 
show signs of ADHD, ASD, and cognitive or 
learning problems during childhood (28;42-44). 
Therefore, the co-occurrence of psychotic symptoms 
with ADHD, ASD, or other childhood-onset 
neurodevelopmental symptoms may prompt 
chromosomal microarray testing to evaluate for 
22q11.2 deletion and any other CNVs that may be 
present. Recent studies of CNVs have suggested that 
various specific genetic duplications and deletions 
can increase an individual’s risk for a broad array of 
neurodevelopmental disorders, including ASD, 
ADHD, various movement disorders, intellectual 
disability, and schizophrenia (24-26;29-33). Thus, the 
presence of a higher number of these problems may 
indicate an increased need for genetic testing. 
The collection of detailed developmental history 
information is also important for research studies, 
particularly those that focus on diagnostic nosology, 
genetics, and individualized treatment. Recent 
research suggests that there are several subtypes of 
schizophrenia, which can be classified according to 
genotypic networks of interacting single-nucleotide 
polymorphisms or specific patterns of schizophrenia 
symptoms (45). Phenotypic subgroups of patients 
with schizophrenia also were found to have distinct 
patterns of fractional anisotropy in a diffusion tensor 
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imaging study of brain white matter (46). Defining 
more genetically homogeneous phenotypic subtypes 
of schizophrenia may need to go beyond the 
examination of schizophrenia symptom patterns to 
include the presence or absence of motor 
abnormalities, specific cognitive deficits, learning 
problems, atypical development patterns, and other 
co-occurring problems. Future research may reveal 
that individuals with distinct patterns of 
developmental history tend to have specific genetic 
abnormalities that lead to the dysfunction of specific 
brain systems. If this is the case, then the evaluation 
of a patient’s developmental history in addition to his 
or her current symptoms may ultimately provide 
information about that patient’s likely responses to 
specific treatments. 
When using the MSHF, the DMHF, or any method 
of collecting a patient’s developmental and 
psychiatric history, several limitations should be kept 
in mind. Memory is not perfect, so retrospective 
reports are not always accurate. There may also be a 
tendency for recall bias to arise from parents or from 
the affected individuals themselves as they think back 
to try to come up with any early risk or causal factors 
that may help to explain the development of a severe 
mental illness. This recall bias can be a particular 
problem in research studies that compare patients 
with severe mental illnesses to healthy individuals. 
Reviewing physical records (e.g., baby books, school 
reports, medical records) rather than relying on an 
individual’s retrospective recall of events may help to 
reduce error, but some behaviors and symptoms of 
interest may not be captured in such records, and 
these additional types of data are not always available.  
Since the creation of the DMHF and the MSHF, 
there have been some advances in the diagnostic 
nomenclature of childhood-onset psychiatric 
disorders. Although the 2005 versions of the forms 
are still appropriate for picking up the problems and 
diagnoses of interest, some modifications may be 
helpful to clarify the types of past diagnoses that were 
present. For example, the term mental retardation has 
now fallen out of favor in the United States, and the 
Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition (DSM-5) instead uses the terms intellectual 
disability or intellectual developmental disorder. Clinicians 
and researchers in other countries may use different 
terminology, so other appropriate adjustments may 
need to be considered for studies outside of the 
United States. Although a revised version of the 
DMHF will include updated terminology, the older 
term mental retardation may be worth mentioning 
parenthetically for the benefit of parents who were 
told in the past (before the DSM-5) that their child 
had this condition and who may not be aware of the 
updated terminology. 
On the basis of experience with the use of this 
instrument, it has also become evident that parents 
sometimes have difficulty distinguishing between the 
terms speech disorder and learning disorder in communication 
or language. Additional questioning by the examiner or 
the inclusion of updated items to help distinguish 
among the various DSM-5 communication disorders 
may be helpful. This could include questions to try to 
determine the presence or absence of a childhood 
language disorder, a speech sound disorder, a 
childhood-onset fluency disorder (e.g., stuttering), or 
a social (pragmatic) communication disorder. In 
some cases, the parent still may not be able to 
provide full information to confirm the specific 
communication disorder diagnosis (e.g., if the parent 
only knows that the child was given a diagnosis of 
“speech/language impairment” by the school), but 
further questions about the specific types of 
speech/language issues observed may provide some 
clarification. 
Since the creation of these instruments, an 
association between obsessive-compulsive disorder 
(OCD) and a future risk of schizophrenia has been 
reported (47). Although the DMHF includes items 
about preoccupation with one’s own thoughts and 
certain repetitive behaviors, these symptoms are not 
specific for OCD, and there is no specific question 
about past OCD diagnosis. Therefore, asking 
additional questions about OCD symptoms may be 
helpful during the course of clinical evaluation. 
Despite the limitations and current lack of 
normative data, the MSHF and DMHF instruments 
can be used to collect valuable developmental history 
information that, according to the existing literature, 
has known relevance to schizophrenia spectrum 
disorders. Future reports of normative and 
psychometric data as well as studies that compare 
scores among various high-risk and diagnostic 
groups may greatly increase the usefulness of these 
instruments for both clinical and research purposes. 
 
Clinical Significance 
When evaluating a patient with a known or suspected 
schizophrenia spectrum disorder, obtaining an 
appropriate developmental history may provide 
information relevant to the patient’s prognosis and 
to decisions about the further diagnostic testing and 
treatment intervention needs of the patient. The self-
report MSHF and parent-report DMHF can be used 
as interviews or self-administered questionnaires to 
collect this developmental history information. 
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